CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Caspian launches with $50M, Lilly support to advance disease-modifying diabetes bet

KO-7246Positive
AI Analysis

Summary

Kura Oncology has spun out Caspian with $50M in funding and support from Eli Lilly to develop KO-7246, a disease-modifying diabetes candidate designed to increase beta cell number and activity to boost insulin production.

Importance:6/10
Sentiment:
0.70
spinoutdiabetesbeta_cellsinsulin_productionfundingLilly_partnership
Related Companies

Read the original article

Published by BioSpace on September 9, 2026 11:00 AM

Read Original